We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

005940:KRXNH INVESTMENT & SECURITIES CO.LTD. Analysis

Data as of 2026-07-20 - not real-time

₩31,000.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

NH Investment & Securities is trading at roughly 31,000 KRW, just above its 20‑day SMA of 30,253 KRW but below the 50‑day SMA, placing it in a neutral technical zone. The MACD histogram has turned positive (≈+156) while the MACD signal is deemed bullish, and volume is on an upward trend, suggesting short‑term buying pressure. Valuation metrics are attractive: a forward P/E of 8.46 versus an industry average of 17.8, a dividend yield of 4.19% with a moderate payout ratio (~36%), and analysts (12) collectively rate the stock as a Buy with a mean target near 42,600 KRW, implying roughly 37% upside. However, the balance sheet shows a very high debt‑to‑equity ratio (>400) and negative operating cash flow, which tempers the optimism despite a solid ROE of ~14.5% and a low beta (~0.93). Market sentiment is extremely positive (Fear‑Greed index 87.9 – “Extreme Greed”), but the 30‑day volatility of over 65% and a max drawdown near 30% highlight notable price swings. In this context, the stock appears undervalued with a strong dividend profile, yet investors should monitor leverage and cash‑flow dynamics.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Positive MACD histogram and bullish signal
  • Price holding above 20‑day SMA with increasing volume
  • Support level at 26,600 KRW providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 8.46 versus industry 17.8 indicating valuation headroom
  • High dividend yield (4.19%) with sustainable payout ratio
  • Analyst consensus (Buy) and target price suggesting ~35% upside

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong ROE (~14.5%) and consistent dividend policy
  • Elevated debt‑to‑equity ratio and negative operating cash flow
  • Exposure to regulatory and market‑cycle risk in capital‑markets sector

Key Metrics & Analysis

Financial Health

Revenue Growth184.80%
Profit Margin7.39%
P/E Ratio8.5
ROE14.47%
ROA1.55%
Debt/Equity424.32
Op. Cash Flow₩-6147995074560
Industry P/E17.8

Technical Analysis

TrendNeutral
RSI50.6
Support₩26,600.00
Resistance₩34,100.00
MA 20₩30,252.50
MA 50₩31,593.00
MA 200₩27,285.55
MACDBullish
VolumeIncreasing
Fear & Greed Index87.91

Valuation

Target Price₩42,583.33
Upside/Downside37.37%
GradeUndervalued
TypeBlend
Dividend Yield4.19%

Risk Assessment

Beta0.93
Volatility65.40%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.